COMMUNIQUÉS West-GlobeNewswire

Monopar Initiates Rolling NDA Submission for ALXN1840 in Wilson Disease
22/07/2026
WILMETTE, Ill., July 22, 2026 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]
Lungpacer Announces New Category III CPT® Codes for AeroPace® Diaphragm Neurostimulation Therapy
22/07/2026
New AMA Category III codes, effective July 1, 2026, support the development of future reimbursement pathways for temporary transvenous diaphragm neurostimulation EXTON, Pa., July 22, 2026 (GLOBE NEWSWIRE) -- Lungpacer [...]
Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases
22/07/2026
RAD101 PET demonstrated 93% concordance with MRI across all evaluable lesions, meeting the trial's primary endpoint. 14 patients with available data from six-month follow-up and biopsy show preliminary 86% (12/14) [...]
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change
22/07/2026
DUBLIN, July 22, 2026 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), (the “Company”) today announced that it plans to change the ratio of the American depositary shares (“ADSs”) representing its Class A [...]
CMR Surgical and NVIDIA showcase future of intelligent surgery with Versius Plus™ at SRS 2026
22/07/2026
CMR Surgical will demonstrate at SRS 2026, for the first time to a surgical audience, the potential for Versius Plus™ to leverage surgical data to help predict how a procedure may unfold. Built on NVIDIA Isaac for [...]
SoldierStrong Donates Two Real® Immersive Systems to Palo Alto VA to Advance Veteran Rehabilitation
22/07/2026
STAMFORD, Conn., July 22, 2026 (GLOBE NEWSWIRE) -- SoldierStrong, a national nonprofit committed to donating revolutionary medical technology to assist injured veterans in taking their next steps forward in life after [...]
Unnatural Products Appoints Finance Leader Neera Ravindran, M.D., M.B.A., as Chief Financial Officer
22/07/2026
SANTA CRUZ, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Unnatural Products, Inc. (UNP), a biotech developing orally-delivered macrocyclic peptides to address previously undruggable targets, today announced the appointment [...]
KC BioHub Awarded $38.1 Million to Advance Regional Biomanufacturing Growth
22/07/2026
Federally recognized Tech Hub positioned to unlock a total of $150 million in federal investment KANSAS CITY, Mo., July 22, 2026 (GLOBE NEWSWIRE) -- The KC BioHub, a program of BioNexus KC , with partners MRIGlobal and [...]
Guidelight Health Opens Eighth Massachusetts Location, Expanding Access to Structured Mental Health Care
22/07/2026
New Andover location and statewide virtual IOP extend timely, evidence-based care across the Commonwealth ANDOVER, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Guidelight Health, a leader in evidence-based mental health [...]
Veraify Launches Groundbreaking AI-Native Security Platform Built for the AI Workforce Era
22/07/2026
New Platform Puts Enterprises in the AI Drivers Seat, with More Control over Shadow AI, AI Workforce, and Sensitive Data Movement, Securing AI Adoption Without Slowing Innovation SUNNYVALE, Calif., July 22, 2026 (GLOBE [...]
Cannara annonce une offre publique de rachat dans le cours normal des activités
22/07/2026
MONTRÉAL, 22 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », « la Société », « nous ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité [...]
Traferox Technologies Receives FDA Premarket Approval for the TorEx Lung Perfusion System
22/07/2026
MISSISSAUGA, Ontario, July 22, 2026 (GLOBE NEWSWIRE) -- Traferox Technologies, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for the TorEx ® Lung Perfusion [...]
Akari Therapeutics CEO Explains Why Growing Industry Demand for Next-Generation ADC Payloads Positions the Company at the Center of a Major Oncology Opportunity
22/07/2026
Virtual Investor "What This Means" segment highlights strategic Whitehawk collaboration, accelerating industry validation of novel ADC payloads, and Akari's differentiated PH1 platform Watch the “What This Means” video [...]
Zevra Therapeutics Announces Details for Q2 2026 Financial Results Call
22/07/2026
BOSTON, Mass., July 22, 2026 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on bringing life-changing therapeutics to people living with rare [...]
New Analysis of Over 50 Studies Showed that All the Non-Prescription CBD Products Researched Fell Short of Therapeutic Efficacy — Reinforcing the Case for Artelo's Optimized ART12.11 CBD Composition
22/07/2026
Review Article Now Published in the British Journal of Clinical Pharmacology Finds Widely Sold Non-Prescription CBD Products at Doses Administered Failed to Provide Adequate Exposure for Positive Biological Effect [...]
Oncotelic Announces Peer-Reviewed Publication Validating Deciparticle™ Technology Supporting the Ongoing Clinical Development of Sapu003 (IV everolimus)
22/07/2026
AGOURA HILLS, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Sapu Nano today announced the publication of a comprehensive peer-reviewed study in Biomedicines describing the [...]
Pacira to Report Second Quarter 2026 Financial Results on Tuesday August 4, 2026
22/07/2026
BRISBANE, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, [...]
BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
22/07/2026
- PDUFA target action date of May 8, 2027 - If approved, encaleret will be the first and only approved therapy specifically indicated for individuals living with ADH1 , representing a potential blockbuster opportunity [...]
Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology
22/07/2026
- Strategic collaboration and equity investment will combine Trinity Biotech's AI-native CGM+ wearable biosensor platform with Latch Medical's innovative intradermal drug delivery technology to develop next-generation [...]

Pages